• Home >>
  • Pharmaceuticals and Healthcare >>
  • Obesity Treatment Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Obesity Treatment Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240297 21st May, 2018 Region : Global Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Obesity Treatment Market with our analysts monitoring the situation across the globe.

Global obesity treatment market, by product type (combination drugs, appetite suppressants, malabsorption and satiety), application (adjusting gastric banding, roux-en-y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures and others) forecast till 2025
Market Scenario

Obesity is a condition arrived when individual eat excess calories that turn in accumulation of excess body fat which shows negative effect on health. Reason behind obesity may be different such as inactivity, family lifestyle, age, unhealthy food habits and medical problem. Adapting sedentary lifestyle, unhealthy diet habits and lack of exercise are led to rising number of obese people this boost the growth of the obesity treatment market. Government initiative to spread awareness regarding negative effect of obesity, rising adaptation of commercially available weight management processes are supporting the growth of the market. Growing awareness related to negative impact of obesity such as osteoarthritis, diabetes, cardiovascular diseases and different type of cancer are fuels the market. Increasing expenditure on R&D activity to developed innovative procedure to tackle the obesity problem are playing vital role in boosting the growth of the market. Growing urbanisation and industrialization in developing countries are responsible for changing lifestyle, resulting growing market for obesity treatment market. Availability of other low cost option to treat obesity can be the challenge to the obesity treatment market. High cost of surgery, low healthcare expenditure and post surgery side effect are some of the factors restraining the growth of the market. 


Segmentation
The global obesity treatment market is segmented on the basis of product type and application. 
On the basis of product type, the market is segmented into combination drugs, appetite suppressants, malabsorption and satiety.
On the basis of application, the market is segmented into adjusting gastric banding, roux-en-y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures and others.

Regional Analysis
Increased number of obese population, availability of technological alternatives and government support & funding are driving the growth of the obesity treatment market in North America. Rising population, changing lifestyle, availability of low cost treatment and rising awareness about negative impact of obesity are contributing the growth of the obesity treatment market in Asia-Pacific region. 


Key Players
Major players profiled in this market are: NutriSystem, Inc., Kellogg Company, Ethicon, Inc., Atkins Nutritionals, Inc., Herbalife Ltd., Covidien plc, Apollo Endosurgery, Amer Sports, Johnson Health Technology, Ltd., Cybex International, Olympus Corporation, Brunswick Corporation, and Technogym SpA.


Segmentation
By Product Type:
• Combination Drugs 
• Appetite Suppressants
• Malabsorption 
• Satiety
  
By Application:
• Adjusting Gastric Banding 
• Roux-en-y Gastric Bypass 
• Sleeve Gastrectomy 
• Biliopancreatic Diversion with Duodenal Switch 
• Endoscopic Procedures 
• Others

By Region:
• North America
• Europe
• Asia-Pacific
• LAMEA

Research Scope
The study for Global Obesity Treatment Market will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2016  Base Year Estimate: 2017  Forecast: 2018 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 
3.6. Market Overview


4. Product Type Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Combination Drugs 
4.2.2. Appetite Suppressants
4.2.3. Malabsorption 
4.2.4. Satiety
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Application Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Adjusting Gastric Banding 
5.2.2. Roux-en-y Gastric Bypass 
5.2.3. Sleeve Gastrectomy 
5.2.4. Biliopancreatic Diversion with Duodenal Switch 
5.2.5. Endoscopic Procedures 
5.2.6. Others
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

6. Regional Overview
6.1. Introduction
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. North America
6.2.1.1. U.S.
6.2.1.2. Canada
6.2.1.3. Mexico 
6.2.2. Europe
6.2.2.1. UK
6.2.2.2. Germany
6.2.2.3. France
6.2.2.4. Italy 
6.2.2.5. Spain
6.2.2.6. Rest of Europe
6.2.3. Asia-Pacific
6.2.3.1. China
6.2.3.2. India
6.2.3.3. Japan
6.2.3.4. South Korea
6.2.3.5. Rest of Asia-Pacific
6.2.4. LAMEA
6.2.4.1. Brazil
6.2.4.2. UAE
6.2.4.3. South Africa
6.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Manufacturer/ Vendor Profile
7.1. The following attributes will be considered while profiling key manufacturers in this industry: 
7.1.1. Company Overview
7.1.2. Financial Synopsis
7.1.3. Recent Developments
7.1.4. R&D Investments (if any)
7.1.5. Strategy Overview (Analyst Perspective)
7.1.6. Product Portfolio
7.2. Companies Profiled
7.2.1. NutriSystem, Inc. 
7.2.2. Kellogg Company 
7.2.3. Ethicon, Inc. 
7.2.4. Atkins Nutritionals, Inc. 
7.2.5. Herbalife Ltd. 
7.2.6. Covidien plc 
7.2.7. Apollo Endosurgery 
7.2.8. Amer Sports 
7.2.9. Johnson Health Technology, Ltd. 
7.2.10. Cybex International 
7.2.11. Olympus Corporation
 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Obesity Treatment Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]